NCT00516074 - A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

exenatide

subcutaneous injection, 5mcg or 10mcg, twice a day

DRUG

placebo

subcutaneous injection, volume equivalent to active, twice a day

Trial Locations (6)

Research Site, Halifax

Research Site, Toronto

Research Site, Etten-Leur

Research Site, Leiden

Research Site, Rotterdam

Research Site, Utrecht